{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:14:44Z","timestamp":1794410084677,"version":"4.9.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims:<\/jats:title>\n            <jats:p>Nuclear protein of the testis (<jats:italic toggle=\"yes\">NUT<\/jats:italic>) carcinoma (NC) is a rare and highly aggressive tumor mainly occurring in adolescents and young adults, defined by the presence of a somatic <jats:italic toggle=\"yes\">NUTM1<\/jats:italic> rearrangement. The aim is to establish internationally harmonized consensus recommendations for the diagnosis and treatment of adolescents and young adults with NC in the framework of the European Reference Network for Paediatric Oncology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The European Cooperative Study Group for Pediatric Rare Tumors developed recommendations according to the Consensus Conference Standard Operating procedure methodology and reviewed by external \u201cexperts.\u201d No evidence of level I to II exists. Recommendations were developed based on published prospective (level III), but more frequently retrospective series (level IV), case reports (level V), and personal expertise (level V). In addition, \u201cstrength\u201d of recommendations were categorized by grading (grade A to E).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Histology is mandatory for the diagnosis of NC, including immunolabeling with anti-NUT antibodies and molecular biology (<jats:italic toggle=\"yes\">NUTM1<\/jats:italic> rearrangement) (level V; grade A). Treatment of NC usually combines aggressive approaches in multimodal regimens. Chemotherapy should be considered as first-line treatment (neoadjuvant vincristine-adriamycin-ifosfamide\/cisplatin-adriamycin-ifsofamide or vincristine-doxorubicin-cyclophosphamide\/ifosfamide-etoposide) for unresectable or metastatic tumor (ie, 3 courses), rapidly followed by local treatment (level IV; grade B). Referral to a specialized surgical oncology center is highly recommended (level V; grade A). In localized NC, a complete microscopic surgical resection should be attempted whenever and as soon as possible, followed by primary irradiation (60 to 70\u00a0Gy) and involved lymph nodes area (level IV; grade B). For head and neck tumors, a systematic neck dissection might be considered, even if N0 (level V; grade C). Adjuvant postirradiation chemotherapy is recommended, for a total of 9 to 12 courses (level IV; grade B). For first-line resected tumors, concomitant adjuvant chemotherapy to radiotherapy may be discussed (level IV; grade B). Targeted therapies and immunotherapeutic regimens should be delivered in the setting of prospective trials (level V; grade B).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This project leads to a consensus strategy based on international experience with this very rare disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002568","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T15:01:59Z","timestamp":1665500519000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations"],"prefix":"10.1097","volume":"45","author":[{"given":"Lauriane","family":"Lemelle","sequence":"first","affiliation":[{"name":"SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Flaadt","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology, University Hospital T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[{"name":"Pediatric oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Moya-Plana","sequence":"additional","affiliation":[{"name":"Surgical and Interventional, Gustave Roussy, Paris-Saclay University, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Timmermann","sequence":"additional","affiliation":[{"name":"Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE)"},{"name":"West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Roganovic","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Clinical Hospital Center Rijeka, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fichera","sequence":"additional","affiliation":[{"name":"Pediatric Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M.","family":"Lauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VIII, Medical Oncology and Pneumology, University of Tuebingen"},{"name":"\u00a7\u00a7German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Ben-Ami","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit, Kaplan Medical Center, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik T.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Clinic of Pediatrics, Dortmund Municipal Hospital, Dortmund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vokuhl","sequence":"additional","affiliation":[{"name":"##Department of Pathology, Section of Pediatric Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bolle","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Fox","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"DuBois","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodriguez-Galindo","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bisogno","sequence":"additional","affiliation":[{"name":"Division, Padova University Hospital, Department of Pediatrics, Hematology-Oncology Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Surun","sequence":"additional","affiliation":[{"name":"SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines B.","family":"Brecht","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Children\u2019s Hospital, Eberhard-Karls-Universit\u00e4t, T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-139X","authenticated-orcid":false,"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[{"name":"SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"R1-20250804","first-page":"120","article-title":"Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors","volume":"110","author":"Ferrari","year":"2019","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"R2-20250804","first-page":"3327","article-title":"Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma","volume":"51","author":"Kubonishi","year":"1991","journal-title":"Cancer Res"},{"key":"R3-20250804","first-page":"304","article-title":"BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","article-title":"Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19)","volume":"13","author":"Kees","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26693","article-title":"NUT carcinoma in children and adults: a multicenter retrospective study","volume":"64","author":"Lemelle","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2350\/09-10-0727-CR.1","article-title":"NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic\/hepatic primary","volume":"13","author":"Shehata","year":"2010","journal-title":"Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","article-title":"Midline carcinoma of children and young adults with NUT rearrangement","volume":"22","author":"French","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/pbc.20755","article-title":"Successful treatment of a child with t(15;19)-positive tumor","volume":"49","author":"Mertens","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000001021","article-title":"NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors","volume":"42","author":"Dickson","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R10-20250804","first-page":"1243","article-title":"The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1018439","DOI":"10.1155\/2019\/1018439","article-title":"An overview of molecular mechanism, clinicopathological factors, and treatment in NUT carcinoma","volume":"2019","author":"Huang","year":"2019","journal-title":"BioMed Res Int"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/OTT.S173056","article-title":"NUT midline carcinoma of the head and neck: current perspectives","volume":"12","author":"Napolitano","year":"2019","journal-title":"OncoTargets Ther"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"R15-20250804","first-page":"815","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.lungcan.2015.10.001","article-title":"NUT carcinoma of the thorax: case report and review of the literature","volume":"90","author":"Harms","year":"2015","journal-title":"Lung Cancer Amst Neth"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","article-title":"Differentiation of NUT midline carcinoma by epigenomic reprogramming","volume":"71","author":"Schwartz","year":"2011","journal-title":"Cancer Res"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543776.2014.859244","article-title":"BET bromodomain inhibitors: a patent review","volume":"24","author":"Garnier","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.acr.2016.04.001","article-title":"Small-molecule targeting of BET proteins in cancer","volume":"131","author":"French","year":"2016","journal-title":"Adv Cancer Res"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-011811-132438","article-title":"Pathogenesis of NUT midline carcinoma","volume":"7","author":"French","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/cncy.21761","article-title":"Cytopathologic features of NUT midline carcinoma: a series of 26 specimens from 13 patients","volume":"124","author":"Bishop","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1111\/1759-7714.13648","article-title":"Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: a single-institute experience of 10 cases","volume":"11","author":"Cho","year":"2020","journal-title":"Thorac Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"pkz093","DOI":"10.1093\/jncics\/pkz093","article-title":"Phase 1 study of molibresib (GSK525762), a bromodomain and extra-terminal domain protein inhibitor, in NUT carcinoma and other solid tumors","volume":"4","author":"Piha-Paul","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jcp.2007.052902","article-title":"Demystified molecular pathology of NUT midline carcinomas","volume":"63","author":"French","year":"2010","journal-title":"J Clin Pathol"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12105-010-0235-x","article-title":"A review of NUT midline carcinoma","volume":"5","author":"Stelow","year":"2011","journal-title":"Head Neck Pathol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00247-011-2272-3","article-title":"NUT midline carcinoma: an imaging case series and review of literature","volume":"42","author":"Polsani","year":"2012","journal-title":"Pediatr Radiol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2407-6-69","article-title":"Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy","volume":"6","author":"Engleson","year":"2006","journal-title":"BMC Cancer"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.COC.0000020960.98562.84","article-title":"Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients","volume":"26","author":"Toretsky","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/1097-0142(20010901)92:5<1195::AID-CNCR1438>3.0.CO;2-3","article-title":"Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course","volume":"92","author":"Vargas","year":"2001","journal-title":"Cancer"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RCT.0000000000001133","article-title":"NUT midline carcinoma of the lung: computed tomography findings in 10 patients","volume":"45","author":"Chang","year":"2021","journal-title":"J Comput Assist Tomogr"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clinimag.2020.07.025","article-title":"Imaging spectrum of NUT carcinomas","volume":"67","author":"Virarkar","year":"2020","journal-title":"Clin Imaging"},{"key":"R34-20250804","first-page":"e288","article-title":"Sinonasal NUT-midline carcinoma\u2014a multimodality approach to diagnosis, staging and post-surgical restaging","volume":"7","author":"Shaikh","year":"2015","journal-title":"Cureus"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12105-013-0479-3","article-title":"NUT midline carcinoma: a case report with a novel translocation and review of the literature","volume":"8","author":"Mills","year":"2014","journal-title":"Head Neck Pathol"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00247-011-2288-8","article-title":"Radiologic features of NUT midline carcinoma in an adolescent","volume":"42","author":"Rosenbaum","year":"2012","journal-title":"Pediatr Radiol"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"100240","DOI":"10.1016\/j.ejro.2020.100240","article-title":"Pediatric thoracic mass lesions: beyond the common","volume":"7","author":"Orman","year":"2020","journal-title":"Eur J Radiol Open"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"W391","DOI":"10.2214\/AJR.13.12401","article-title":"Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy","volume":"203","author":"Bair","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/RLU.0b013e31821c9a23","article-title":"FDG PET\/CT imaging of NUT midline carcinoma","volume":"36","author":"Niederkohr","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/RLU.0000000000000795","article-title":"NUT midline carcinoma in elderly patients: usefulness of 18F-FDG PET\/CT for treatment assessment","volume":"40","author":"Kawase","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R41-20250804","first-page":"53","article-title":"Staging and evaluation of neoadjuvant chemotherapy response with 18F-FDG PET\/CT in NUT-midline carcinoma in a child: a case report and review of the literature","volume":"34","author":"Ciftci","year":"2015","journal-title":"Rev Espanola Med Nucl E Imagen Mol"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/000348941112000810","article-title":"NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl","volume":"120","author":"Rutt","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1200\/JCO.2010.32.7486","article-title":"NUT midline carcinoma in a young woman","volume":"29","author":"Teo","year":"2011","journal-title":"J Clin Oncol"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/1450-1147.207284","article-title":"Nuclear protein in testis midline carcinoma presenting in an infant as a pericardial mass with staging by 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography","volume":"16","author":"Perkins","year":"2017","journal-title":"World J Nucl Med"},{"key":"R45-20250804","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/PAS.0b013e318258f03b","article-title":"Pathologic characteristics of NUT midline carcinoma arising in the mediastinum","volume":"36","author":"Evans","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/PAS.0b013e318254ce54","article-title":"NUT midline carcinomas of the sinonasal tract","volume":"36","author":"Bishop","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R47-20250804","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R48-20250804","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pin.12727","article-title":"NUT carcinoma: clinicopathologic features, pathogenesis, and treatment","volume":"68","author":"French","year":"2018","journal-title":"Pathol Int"},{"key":"R49-20250804","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12105-013-0428-1","article-title":"The importance of diagnosing NUT midline carcinoma","volume":"7","author":"French","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R50-20250804","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/dc.23291","article-title":"Cytologic findings of NUT midline carcinoma in the hilum of the lung","volume":"43","author":"Policarpio-Nicolas","year":"2015","journal-title":"Diagn Cytopathol"},{"key":"R51-20250804","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1470-2045(15)00583-5","article-title":"Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study","volume":"17","author":"Italiano","year":"2016","journal-title":"Lancet Oncol"},{"key":"R52-20250804","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov"},{"key":"R53-20250804","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/onc.2012.487","article-title":"Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma","volume":"32","author":"Thompson-Wicking","year":"2013","journal-title":"Oncogene"},{"key":"R54-20250804","first-page":"1","article-title":"A rare case of NUT midline carcinoma","volume":"3","author":"Ball","year":"2012","journal-title":"Gynecol Oncol Case Rep"},{"key":"R55-20250804","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.22838","article-title":"Emerging entities in NUTM1-rearranged neoplasms","volume":"59","author":"McEvoy","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"R56-20250804","first-page":"764","article-title":"NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum","volume":"32","author":"Stevens","year":"2019","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"R57-20250804","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.adaj.2017.09.011","article-title":"Dental disease before radiotherapy in patients with head and neck cancer: Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients","volume":"148","author":"Brennan","year":"2017","journal-title":"J Am Dent Assoc 1939"},{"key":"R58-20250804","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00784-008-0229-1","article-title":"Dental therapy before and after radiotherapy\u2014an evaluation on patients with head and neck malignancies","volume":"13","author":"Sennhenn-Kirchner","year":"2009","journal-title":"Clin Oral Investig"},{"key":"R59-20250804","doi-asserted-by":"crossref","first-page":"424","DOI":"10.12659\/AJCR.893879","article-title":"Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma","volume":"16","author":"Maur","year":"2015","journal-title":"Am J Case Rep"},{"key":"R60-20250804","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/1973947815Y.0000000046","article-title":"First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4\/NUT translocation","volume":"28","author":"Vulsteke","year":"2016","journal-title":"J Chemother Florence Italy"},{"key":"R61-20250804","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1097\/MPH.0000000000001860","article-title":"Metastatic NUT midline carcinoma treated with aggressive neoadjuvant chemotherapy, radiation, and resection: a case report and review of the literature","volume":"43","author":"Sopfe","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R62-20250804","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/08880018.2017.1363839","article-title":"Pediatric NUT-midline carcinoma: therapeutic success employing a sarcoma based multimodal approach","volume":"34","author":"Storck","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R63-20250804","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1002\/pbc.26946","article-title":"Long-term survival after relapsed NUT carcinoma of the larynx","volume":"65","author":"Vorstenbosch","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R64-20250804","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1634\/theoncologist.2019-0358","article-title":"Pediatric NUT carcinoma is a rare and challenging tumor: single center experience of five children","volume":"24","author":"Prasad","year":"2019","journal-title":"Oncologist"},{"key":"R65-20250804","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26334","article-title":"Bromodomain and extraterminal protein inhibitors in pediatrics: a review of the literature","volume":"64","author":"Jim\u00e9nez","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R66-20250804","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"R67-20250804","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/bjc.2014.54","article-title":"Comparative drug screening in NUT midline carcinoma","volume":"110","author":"Beesley","year":"2014","journal-title":"Br J Cancer"},{"key":"R68-20250804","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1634\/theoncologist.2018-0477","article-title":"Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study","volume":"24","author":"Jung","year":"2019","journal-title":"Oncologist"},{"key":"R69-20250804","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1091\/mbc.e09-05-0380","article-title":"Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription","volume":"20","author":"Dey","year":"2009","journal-title":"Mol Biol Cell"},{"key":"R70-20250804","first-page":"3898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Mol Basel Switz"},{"key":"R71-20250804","first-page":"115","article-title":"Bromodomain and extra-terminal inhibitors\u2014a consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE","volume":"146","author":"Pearson","year":"2021","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"R72-20250804","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pbc.25350","article-title":"Histone deacetylase inhibitor for NUT midline carcinoma","volume":"62","author":"Maher","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R73-20250804","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00432-017-2401-y","article-title":"A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma","volume":"143","author":"Qiu","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"R74-20250804","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1535-7163.MCT-20-0087","article-title":"Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734","volume":"19","author":"Morrison-Smith","year":"2020","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:08:48Z","timestamp":1754338128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002568","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"2022-04-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}